Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes.
Mattila
Catharina
C
National Public Health Institute, Mannerheimintie 166, 00300 Helsinki, Finland.
Knekt
Paul
P
Männistö
Satu
S
Rissanen
Harri
H
Laaksonen
Maarit A
MA
Montonen
Jukka
J
Reunanen
Antti
A
D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology* / Q000517:prevention & control; D019587:Dietary Supplements; D005260:Female; D005387:Finland / Q000453:epidemiology; D006306:Health Surveys; D006801:Humans; D050417:Insulin-Secreting Cells / Q000502:physiology; D008297:Male; D008875:Middle Aged; D018570:Risk Assessment; D014807:Vitamin D / Q000031:analogs & derivatives* / Q000097:blood; D014808:Vitamin D Deficiency / Q000503:physiopathology; D014815:Vitamins / Q000008:administration & dosage
D015415:Biomarkers; D014815:Vitamins; D014807:Vitamin D; C104450:25-hydroxyvitamin D